In accordance with the final direction for the second cycle from the Drug Price Negotiation System, drug providers with a particular drug could have till February 28, 2025 to come to a decision if they're going to be involved in negotiations. In negotiating with taking part brands, CMS will contemplate the chosen drug’s medical advantage, the ext